Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
Author | |
---|---|
Abstract | :
Walking impairment causes disability and reduced quality of life in patients with multiple sclerosis (MS). |
Year of Publication | :
2018
|
Journal | :
Multiple sclerosis (Houndmills, Basingstoke, England)
|
Number of Pages | :
1352458518754716
|
Date Published | :
2018
|
ISSN Number | :
1352-4585
|
URL | :
http://journals.sagepub.com/doi/abs/10.1177/1352458518754716?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
|
DOI | :
10.1177/1352458518754716
|
Short Title | :
Mult Scler
|
Download citation |